ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1977

The Westergren Sedimentation Rate: To Be or Not to Be! The Westergren Sedimentation Rate is being “Killed” but has not “Died”.

John Goldman1, Michael Goldman2 and Glenn R. Parris3, 1Emory University St Josephs Hospital, Atlanta, GA, 2SENTA Southeastern Ear, Nose, Throat and Allergy, Atlanta, GA, 3PARRIS & ASSOCIATES, Lilburn, GA

Meeting: ACR Convergence 2025

Keywords: Clinical practice guidelines, functional status, Measurement, physical function

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1972–1989) Measures & Measurement of Healthcare Quality Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The Westergren Sedimentation Rate (WSR) is a simple, cost-effective laboratory test commonly used by rheumatologists to assess systemic inflammation. This study was initiated to evaluate the current status and availability of the erythrocyte sedimentation rate (ESR) for practicing physicians. Specifically, we aim to compare the accuracy and concordance of the manually performed STAT WSR, processed within two hours of sample collection, with the ESR performed at the central laboratory (CRL), which uses automated capillary photometry. We are particularly interested in whether delays in specimen transport to the CRL impact the reliability of ESR results compared to the more immediate manual WSR.

Methods: We reviewed WSR reports for 106 de-identified patients (Table 1) tested in the POL, and for whom a specimen was also sent the same day to a CRL for erythrocyte sedimentation rate (ESR) testing. This dual testing was initiated after observing that ESR results from the CRL were frequently lower than the POL WSR. Notably, no charges for the in-office WSR.The POL used manual WSR testing. In contrast, the CRL utilized the iSED® system by Alcor, an automated method that directly measures red blood cell aggregation using capillary photometry during rouleaux formation. We also investigated whether the time interval between specimen collection and analysis at the CRL had an impact on ESR comparability.

Results: The ESR measured in the POL was significantly higher than that in the CRL, as demonstrated by both statistical analysis and Passing-Bablok regression (Table 2 and Figure 1). Additionally, we assessed the coefficient of variation (CV) for manual sedimentation rates using three tube comparisons.

Conclusion: This study was conducted to assess the rationale behind requiring WSR specimens to be sent to a CRL and to evaluate how effectively the CRL performs ESR testing. Although the CRL claims its methodology is equivalent to WSR, its ESR testing process is not performed while the specimen is fresh.A WSR must be performed rapidly—ideally within 2 hours of specimen collection—while the blood is still fresh. In the POL it is ordered as a STAT test. Many American patients are covered under insurance plans that either require testing through a CRL or permit POL testing. However, POL testing requires full CLIA certification, which entails substantial administrative overhead, including paperwork, inspections, and associated costs. In-office WSR, by contrast, is a CLIA-waived test, making it a practical option.The CRL uses automated photocytometry for large-scale ESR testing. However, it remains uncertain whether this automated method provides equivalent clinical value when compared to manual WSR. The core concern is the total turnaround time, from the moment the blood is drawn to when the ESR is actually performed. Some CRLs are located far from the physician’s office, in some cases even out of state, necessitating courier or air transport. Often, specimens drawn throughout the day are not shipped until evening. Both resulted in processing delays up to 24 hours or more. This delay could significantly affect clinical decision-making, especially when monitoring conditions such as rheumatoid arthritis using metrics like the DAS28ESR.

Supporting image 1Table 1. Patients

Supporting image 2Table 2. Statistics

Supporting image 3Figure 1. Passing Bablok of the Westergren Sedimentation Rate Compared to the iSED Sedimentation Rate


Disclosures: J. Goldman: None; M. Goldman: None; G. Parris: None.

To cite this abstract in AMA style:

Goldman J, Goldman M, Parris G. The Westergren Sedimentation Rate: To Be or Not to Be! The Westergren Sedimentation Rate is being “Killed” but has not “Died”. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-westergren-sedimentation-rate-to-be-or-not-to-be-the-westergren-sedimentation-rate-is-being-killed-but-has-not-died/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-westergren-sedimentation-rate-to-be-or-not-to-be-the-westergren-sedimentation-rate-is-being-killed-but-has-not-died/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology